Defunct Company
Total Trials
7
As Lead Sponsor
As Collaborator
0
Total Enrollment
829
NCT00626184
A Phase 1, Study of the Safety and Tolerability of ALV003 in Healthy Adult Volunteers and Subjects With Well-Controlled Celiac Disease
Phase: Phase 1
Role: Lead Sponsor
Start: Feb 29, 2008
Completion: Jul 31, 2008
NCT00669825
Study of ALV003 in Healthy Adult Volunteers and Subjects With Well-Controlled Celiac Disease Following a Gluten-Containing Meal
Start: Mar 31, 2008
Completion: Oct 31, 2008
NCT00859391
Effects of Gluten Digestion With ALV003
Phase: N/A
Start: May 31, 2008
Completion: Jun 30, 2008
NCT00959114
Safety and Efficacy of ALV003 for the Treatment of Celiac Disease
Phase: Phase 2
Start: Aug 31, 2009
Completion: Oct 31, 2010
NCT01255696
Safety and Efficacy of Varying Methods of ALV003 Administration for the Treatment of Celiac Disease
Start: Nov 30, 2010
Completion: Jun 30, 2011
NCT01560169
Evaluation of Patient Reported Outcome Instruments in Celiac Disease Patients
Start: Mar 31, 2012
Completion: Sep 30, 2013
NCT01917630
Evaluation of the Efficacy and Safety of ALV003 in Symptomatic in Celiac Disease Patients
Start: Aug 31, 2013
Completion: Jun 30, 2015